Description  Claims  Cited references 

WO2011050323A   [0004] 
WO2012109263A   [0004] 
WO2012164076A   [0005] 
WO2011073112A   [0006] 
WO2005089733A   [0006] 

Nat Rev Gastroenterol Hepatol   [0001] 
Cell Host Microbe   [0002] 
Proc. Natl. Acad. Sci.   [0002] 
Gastroenterology   [0002] 
Inflamm Bowel Dis.   [0002] 
J. Clin. Invest.   [0002] 
JEM   [0002] 
J. Med. Chem.   [0003] 
Protective Groups in Organic Synthesis   [0079]  [0079] 
pharmaceutically acceptable salts   [0109] 
BURGER'S MEDICINAL CHEMISTRY AND DRUG DISCOVERY   [0115] 
Remington's Pharmaceutical Sciences   [0122] 
Clin. Pharmacokinet.   [0152] 
Arch. Exp. Pathol Pharmacol.   [0152] 
Adv. Enzyme Regul.   [0152] 
J. Org. Chem.   [0164] 
J. Org. Chem.   [0164] 
Angew. Chem. Int. Ed.   [0168]  [0257] 
JOC   [0170] 
Tet. Lett.   [0197]  [0378]  [0389] 
PNAS   [0199]  [0200]  [0210] 
Org Lett   [0223] 
Tetrahedron: Asymmetry   [0239] 
Tetrahedron   [0411] 
Infect Immun.   [0534] 
J. Med. Chem.   [0542]